Achieve Life Sciences (ACHV) Interest Expenses (2018 - 2026)

Achieve Life Sciences (ACHV) has 16 years of Interest Expenses data on file, last reported at $274000.0 in Q1 2026.

• Quarterly Interest Expenses rose 48.11% year-over-year to $274000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $672000.0 (down 56.7% YoY) and the FY2025 annual result came in at $1.4 million, down 35.78% from the prior year.
• Interest Expenses advanced to $274000.0 in Q1 2026, from $15000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $2.8 million in Q4 2023 to a low of $15000.0 in Q4 2025.
• A 5-year average of $641117.6 and a median of $404000.0 in 2022 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2022 — Interest Expenses soared 11526.67% — and 2024, when it tumbled 92.99%.
• Tracing ACHV's Interest Expenses over 5 years: stood at $1.7 million in 2022, then jumped by 61.12% to $2.8 million in 2023, then plunged by 92.99% to $197000.0 in 2024, then sank by 92.39% to $15000.0 in 2025, then surged by 1726.67% to $274000.0 in 2026.
• The last three Interest Expenses figures came in at $274000.0 (Q1 2026), $15000.0 (Q4 2025), and $192000.0 (Q3 2025), per Business Quant data.